Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 191
Selected: 0
NCT IDTitle
NCT04128163Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk
NCT05446883QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
NCT07235176Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients
NCT06446310Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
NCT03312283Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD
NCT05058118Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)
NCT07018050Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma
NCT07102004Study of MHB088C for Patients With Advanced Solid Malignant Tumors
NCT07272590Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors
NCT02908958Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
NCT04629846Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.
NCT06954246A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT04705519Nab-paclitaxel Combined with Bevacizumab in the Treatment of Metastatic Extrapulmonary Neuroendocrine Carcinoma
NCT05801107Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
NCT06822985QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma
NCT05932888Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects
NCT05802342A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer
NCT07104110Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer
NCT07294300A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies
NCT06254235Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers
NCT07089186Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections
NCT07040228A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer
NCT04234594Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
NCT06261359A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma
NCT07258394Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
NCT05801094A Phase I Study of QL1604 for Advanced Solid Tumors
NCT00404989Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT07127822Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT06799559Study on the Efficacy and Safety of QLM1016 in Schizophrenia
NCT06760676A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy
NCT06019013A Study of QLF3108 in Participants With Advanced Solid Tumor
NCT05973149Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer
NCT04435652A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.
NCT06994507GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
NCT06041035A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors
NCT07001839A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus
NCT07173595A Phase I Clinical Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Preliminary Antitumor Activity of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies
NCT06750341Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol
NCT05150405A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors
NCT05649761A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors
NCT05603039A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma
NCT06406205A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis
NCT06940336To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
NCT06754644A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
NCT05055687Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)
NCT07256782A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
NCT06880276Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT06613880Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
NCT01931943A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer
NCT06949761A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation